A database of FDA approved therapeutic peptides and proteins
| ID1038 | ThPPIDTh1007 | NameLeuprolide | Peptide SequencePHWSYLLR Full view | Length8 | Functional ClassificationIIa | DiseaseCancer | BrandEligard | CompanyAtrix Labs/QLT In | Physical AppearanceSuspension | Route of AdministartionSubcutaneous Injection | CategoryAntineoplastic Agents, Hormonal and fertility agents, estrogen antagonists | TargetGonadotropin-releasing hormone receptor |
| ID1039 | ThPPIDTh1007 | NameLeuprolide | Peptide SequencePHWSYLLR Full view | Length8 | Functional ClassificationIIa | DiseaseCancer | BrandEnantone | CompanyTakeda | Physical AppearanceSolution | Route of AdministartionInjection | CategoryAntineoplastic Agents, Hormonal and fertility agents, estrogen antagonists | TargetGonadotropin-releasing hormone receptor |
| ID1040 | ThPPIDTh1007 | NameLeuprolide | Peptide SequencePHWSYLLR Full view | Length8 | Functional ClassificationIIa | DiseaseCancer | BrandLeuplin | CompanyTakeda | Physical AppearanceN.A. | Route of AdministartionInjection | CategoryAntineoplastic Agents, Hormonal and fertility agents, estrogen antagonists | TargetGonadotropin-releasing hormone receptor |
| ID1041 | ThPPIDTh1007 | NameLeuprolide | Peptide SequencePHWSYLLR Full view | Length8 | Functional ClassificationIIa | DiseaseCancer | BrandLeuProMaxx | CompanyBaxter/Teva | Physical AppearanceN.A. | Route of AdministartionN.A. | CategoryAntineoplastic Agents, Hormonal and fertility agents, estrogen antagonists | TargetGonadotropin-releasing hormone receptor |
| ID1042 | ThPPIDTh1007 | NameLeuprolide | Peptide SequencePHWSYLLR Full view | Length8 | Functional ClassificationIIa | DiseaseCancer | BrandLeupromer | CompanyN.A. | Physical AppearanceN.A. | Route of AdministartionInjection | CategoryAntineoplastic Agents, Hormonal and fertility agents, estrogen antagonists | TargetGonadotropin-releasing hormone receptor |
| ID1043 | ThPPIDTh1007 | NameLeuprolide | Peptide SequencePHWSYLLR Full view | Length8 | Functional ClassificationIIa | DiseaseCancer | BrandLupron | CompanyAbbott/TAP Pharmaceuticals | Physical AppearanceN.A. | Route of AdministartionInjection | CategoryAntineoplastic Agents, Hormonal and fertility agents, estrogen antagonists | TargetGonadotropin-releasing hormone receptor |
| ID1044 | ThPPIDTh1007 | NameLeuprolide | Peptide SequencePHWSYLLR Full view | Length8 | Functional ClassificationIIa | DiseaseCancer | BrandLutrate | CompanyN.A. | Physical AppearanceN.A. | Route of AdministartionN.A. | CategoryAntineoplastic Agents, Hormonal and fertility agents, estrogen antagonists | TargetGonadotropin-releasing hormone receptor |
| ID1045 | ThPPIDTh1007 | NameLeuprolide | Peptide SequencePHWSYLLR Full view | Length8 | Functional ClassificationIIa | DiseaseCancer | BrandMemryte | CompanyCuraxis | Physical AppearanceN.A. | Route of AdministartionN.A. | CategoryAntineoplastic Agents, Hormonal and fertility agents, estrogen antagonists | TargetGonadotropin-releasing hormone receptor |
| ID1046 | ThPPIDTh1007 | NameLeuprolide | Peptide SequencePHWSYLLR Full view | Length8 | Functional ClassificationIIa | DiseaseCancer | BrandProstap 3 | CompanyTakeda UK Limited | Physical AppearanceN.A. | Route of AdministartionN.A. | CategoryAntineoplastic Agents, Hormonal and fertility agents, estrogen antagonists | TargetGonadotropin-releasing hormone receptor |
| ID1047 | ThPPIDTh1007 | NameLeuprolide | Peptide SequencePHWSYLLR Full view | Length8 | Functional ClassificationIIa | DiseaseCancer | BrandProstap SR | CompanyTakeda UK Limited | Physical AppearanceN.A. | Route of AdministartionN.A. | CategoryAntineoplastic Agents, Hormonal and fertility agents, estrogen antagonists | TargetGonadotropin-releasing hormone receptor |
| ID1048 | ThPPIDTh1007 | NameLeuprolide | Peptide SequencePHWSYLLR Full view | Length8 | Functional ClassificationIIa | DiseaseCancer | BrandViadur | CompanyBayer AG | Physical AppearanceN.A. | Route of AdministartionN.A. | CategoryAntineoplastic Agents, Hormonal and fertility agents, estrogen antagonists | TargetGonadotropin-releasing hormone receptor |
| ID1215 | ThPPIDTh1029 | NameMenotropins | Peptide SequenceAlpha-Chain(LH):APD< Full view | Length222 | Functional ClassificationIb | DiseaseHormonal disorders | BrandMenopur | CompanyN.A. | Physical AppearanceSterile, lyophilized powder which is reconstitution with sterile 0.9% Sodium Chloride Injection. | Route of AdministartionSubcutaneous Injection | CategoryFertility Agents | TargetFollicle-stimulating hormone receptor,Lutropin-choriogonadotropic hormone receptor |
| ID1216 | ThPPIDTh1029 | NameMenotropins | Peptide SequenceAlpha-Chain(LH):APD< Full view | Length222 | Functional ClassificationIb | DiseaseHormonal disorders | BrandRepronex | CompanyN.A. | Physical AppearanceSterile, lyophilized form | Route of AdministartionSubcutaneous or Intramuscular Injection. | CategoryFertility Agents | TargetFollicle-stimulating hormone receptor,Lutropin-choriogonadotropic hormone receptor |
| ID1269 | ThPPIDTh1039 | NameLutropin alfa | Peptide SequenceAlpha Chain: APDVQDC Full view | Length213 | Functional ClassificationIb | DiseaseHormonal | BrandLuveris | CompanySerono | Physical AppearanceWhite lyophilised pellet withg clear colourless solvent to make solution | Route of AdministartionSubcutaneous (SC) administration | CategoryFertility Agents | TargetLutropin-choriogonadotropic hormone receptor |
| ID1363 | ThPPIDTh1052 | NameEptifibatide | Peptide SequenceMpr-Har-Gly-Asp-Trp- Full view | Length7 | Functional ClassificationIb | DiseaseHematological/Metabolic | BrandINTEGRILIN | CompanySchering-Plough/Essex | Physical AppearanceClear, colorless, sterile, non-pyrogenic solution of Eptifibatide | Route of AdministartionInjection Solution for IIntravenousUse | CategoryPlatelet Aggregation Inhibitors | TargetLutropin-choriogonadotropic hormone receptor,Follicle-stimulating hormone receptor |
| ID1372 | ThPPIDTh1055 | NameFollitropin beta | Peptide SequenceA Chain: APDVQDCPECT Full view | Length204 | Functional ClassificationIb | DiseaseHormonal disorders | BrandFollistim AQ | CompanyMerck | Physical AppearanceSterile aqueous solution | Route of AdministartionSubcutaneous or Intramuscular administration | CategoryFertility Agents | TargetFollicle-stimulating hormone receptor |
| ID1419 | ThPPIDTh1070 | NameBotulinum Toxin Type A | Peptide SequenceMPFVNKQFNYKDPVNGVDIA Full view | Length1296 | Functional ClassificationIc | DiseaseNeurological Disorder | BrandBOTOX | CompanyAllergan | Physical AppearanceSterile, vacuum-dried purified botulinum toxin type A, produced from fermentation of Hall strainClostridium botulinum type A | Route of AdministartionIntramuscular, intradetrusor and intradermal use | CategoryNeuromuscular Blocking Agents, Anti-Wrinkle Agents and Antidystonic Agents | TargetGrowth hormone receptor |
| ID1420 | ThPPIDTh1070 | NameBotulinum Toxin Type A | Peptide SequenceMPFVNKQFNYKDPVNGVDIA Full view | Length1296 | Functional ClassificationIc | DiseaseNeurological Disorder | BrandDysport | CompanyIpsen Pharmaceuticals | Physical AppearanceSterile vial for reconstitution | Route of AdministartionIntramuscular Injection | CategoryNeuromuscular Blocking Agents, Anti-Wrinkle Agents and Antidystonic Agents | TargetGrowth hormone receptor |
| ID1421 | ThPPIDTh1070 | NameBotulinum Toxin Type A | Peptide SequenceMPFVNKQFNYKDPVNGVDIA Full view | Length1296 | Functional ClassificationIc | DiseaseNeurological Disorder | BrandXeomin | CompanyMERZ AESTHETICS | Physical AppearanceSterile white to off-white lyophilized powder after reconstitution with preservative-free 0.9% Saline for Injection. | Route of AdministartionIntramuscular Injection | CategoryNeuromuscular Blocking Agents, Anti-Wrinkle Agents and Antidystonic Agents | TargetGrowth hormone receptor |
| ID1451 | ThPPIDTh1082 | NameFilgrastim | Peptide SequenceMTPLGPASSLPQSFLLKCLE Full view | Length175 | Functional ClassificationIb | DiseaseImmunological | BrandN.A. | CompanyN.A. | Physical AppearanceN.A. | Route of AdministartionN.A. | CategoryImmunosuppressive Agents, Antineutropenic Agents and Hematopoietic Agents | TargetLutropin-choriogonadotropic hormone receptor,Follicle-stimulating hormone receptor |
| ID1500 | ThPPIDTh1103 | NameCosyntropin | Peptide SequenceACTH(1-24): SYSM Full view | Length24 | Functional ClassificationIV | DiseaseHormonal | BrandCortrosyn | CompanyAmphastar Pharmaceuticals | Physical AppearanceN.A. | Route of AdministartionIntravenous injection, Intravenous infusion, Intramuscular injection | CategoryHormones and Diagnostic Agents | TargetAdrenocorticotropic hormone receptor |
| ID1535 | ThPPIDTh1114 | NamePreotact | Peptide SequenceParathyroid hormone: Full view | Length84 | Functional ClassificationIb | DiseaseOsteological | BrandPreotact | CompanyNycomed | Physical AppearanceN.A. | Route of AdministartionSubcutaneous injection | CategoryN.A. | TargetParathyroid hormone/parathyroid hormone-related peptide receptor,Parathyroid hormone 2 receptor |
| ID1556 | ThPPIDTh1120 | NameTeriparatide | Peptide SequenceParathyroid hormone Full view | Length34 | Functional ClassificationIb | DiseaseOsteological | BrandForteo | CompanyEli Lilly and Company | Physical AppearanceSterile, colorless, clear, isotonic solution | Route of AdministartionSubcutaneous injection | CategoryBone Density Conservation Agents | TargetParathyroid hormone/parathyroid hormone-related peptide receptor |
| ID1600 | ThPPIDTh1127 | NameBuserelin | Peptide SequenceN.A. Full view | Length0 | Functional ClassificationIIIc | DiseaseCancer/Hormonal | BrandSuprecur (Nasal Spray Solution) | CompanySanofi-Aventis | Physical Appearance150 micrograms Nasal Spray Solution | Route of AdministartionNasal spray | CategoryN.A. | TargetLutropin-choriogonadotropic hormone receptor,Gonadotropin-releasing hormone receptor |
| ID1601 | ThPPIDTh1127 | NameBuserelin | Peptide SequencepGlu-His-Trp-Ser-Tyr Full view | Length9 | Functional ClassificationIIIc | DiseaseCancer/Hormonal | BrandSuprecur (injection) | CompanySanofi-Aventis | Physical Appearance1mg/ml Injection | Route of AdministartionSubcutaneous injection | CategoryN.A. | TargetLutropin-choriogonadotropic hormone receptor,Gonadotropin-releasing hormone receptor |
| ID1603 | ThPPIDTh1129 | NameTesamorelin | Peptide SequenceYADAIFTNSYRKVLGQLSAR Full view | Length44 | Functional ClassificationIb | DiseaseHormonal | BrandEgrifta | CompanyTheratechnologies | Physical AppearanceSterile, white to off-white, preservative-free lyophilized powder | Route of AdministartionSubcutaneous injection | CategoryN.A. | TargetGrowth hormone-releasing hormone receptor |
| ID1655 | ThPPIDTh1151 | NameSomatotropin Recombinant | Peptide SequenceFPTIPLSRLFDNAMLRAHRL Full view | Length192 | Functional ClassificationIb | DiseaseHormonal/Metabolic | BrandNutropinAQ | CompanyGenentech Inc. | Physical AppearanceSterile, white lyophilized powder intended for subcutaneous administration after reconstitution with Bacteriostatic Water | Route of AdministartionSubcutaneous administration | CategoryHormone Replacement Agents | TargetGrowth hormone receptor, Prolactin receptor |
| ID1656 | ThPPIDTh1151 | NameSomatotropin Recombinant | Peptide SequenceFPTIPLSRLFDNAMLRAHRL Full view | Length192 | Functional ClassificationIb | DiseaseHormonal/Metabolic | BrandBioTropin | CompanyBio-Technology General (Israel) Ltd. | Physical AppearanceSterile, white, lyophilized powder | Route of AdministartionSubcutaneous administration | CategoryHormone Replacement Agents | TargetGrowth hormone receptor, Prolactin receptor |
| ID1657 | ThPPIDTh1151 | NameSomatotropin Recombinant | Peptide SequenceFPTIPLSRLFDNAMLRAHRL Full view | Length192 | Functional ClassificationIb | DiseaseHormonal/Metabolic | BrandProtropin | CompanyGenentech Inc. | Physical AppearanceSterile, white, lyophilized powder | Route of AdministartionIntramuscular or subcutaneous administration | CategoryHormone Replacement Agents | TargetGrowth hormone receptor, Prolactin receptor |
| ID1664 | ThPPIDTh1156 | NameAbarelix | Peptide SequenceN.A. Full view | Length0 | Functional ClassificationIIIc | DiseaseHormonal | BrandPlenaxis | CompanySpeciality european pharma | Physical AppearanceWhite to off-white sterile dry powder | Route of AdministartionIntramuscular Injection | CategoryAnti-Testosterone Agents | TargetGonadotropin-releasing hormone receptor |
| ID1666 | ThPPIDTh1157 | NameSermorelin | Peptide SequenceYADAIFTNSYRKVLGQLSAR Full view | Length30 | Functional ClassificationIa | DiseaseHormonal | BrandSermorelin acetate | CompanyEmd serono inc | Physical AppearanceSterile, non-pyrogenic, lyophilized powder | Route of AdministartionSubcutaneous Injection | CategoryHormone Replacement Agents | TargetGrowth hormone-releasing hormone receptor |
| ID1833 | ThPPIDTh1223 | NameChorionic Gonadotropin (Human) | Peptide SequenceAlpha Chain: APDVQDC Full view | Length237 | Functional ClassificationIa | DiseaseHormonal Disorders | BrandOvidrel | CompanyEmd Serono | Physical AppearanceInjection, solution | Route of AdministartionSubcutaneous | CategoryHormones | TargetLutropin-choriogonadotropic hormone receptor |
| ID1834 | ThPPIDTh1223 | NameChorionic Gonadotropin (Human) | Peptide SequenceAlpha Chain: APDVQDC Full view | Length237 | Functional ClassificationIa | DiseaseHormonal Disorders | BrandPregnyl | CompanyPhysicians Total Care, Inc. | Physical AppearanceInjection, Solution | Route of AdministartionIntramuscular, Subcutaneous | CategoryHormones | TargetLutropin-choriogonadotropic hormone receptor |
| ID1835 | ThPPIDTh1224 | NameChorionic Gonadotropin (Recombinant) | Peptide SequenceAlpha chain : APDVQD Full view | Length237 | Functional ClassificationIa | DiseaseHormonal Disorders | BrandOvitrelle | CompanyMerck Serono Europe Limited | Physical Appearancepowder and solvent to be made up into a solution | Route of AdministartionSubcutaneous | CategoryHormones | TargetLutropin-choriogonadotropic hormone receptor, Follicle-stimulating hormone receptor |
| ID1849 | ThPPIDTh1237 | NameSomatropin recombinant | Peptide SequenceFPTIPLSRLFDNAMLRAHRL Full view | Length191 | Functional ClassificationIb | DiseaseHormonal Disorders | BrandBioTropin | CompanyBiotech General | Physical AppearancePowder and Solvent for Solution | Route of AdministartionSubcutaneous | CategoryHormones, Hormone Substitutes, and Hormone Antagonists | TargetGrowth hormone receptor, Prolactin receptor |
| ID1850 | ThPPIDTh1237 | NameSomatropin recombinant | Peptide SequenceFPTIPLSRLFDNAMLRAHRL Full view | Length191 | Functional ClassificationIb | DiseaseHormonal Disorders | BrandNutropinAQ | CompanyGenentech Inc. | Physical AppearanceSterile liquid | Route of AdministartionSubcutaneous | CategoryHormones, Hormone Substitutes, and Hormone Antagonists | TargetGrowth hormone receptor, Prolactin receptor |